Adrenaline pens overprescribed in children, study suggests

The reasons for the 'exponential' increase in prescribing of adrenaline auto-injectors (AAIs) in children are unclear, say UK researchers.

Using data from The Health Improvement Network (THIN) database for the period 2000–2012, the researchers found that 23,837 children aged 0–17 years were deemed high risk by their GPs, and were prescribed 98,737 AAI devices.

These figures equate to 4.67 high-risk children (95% CI 4.66–4.69) and 19.4 devices (95% CI 19.2–19.5) per 1000 person–years.

About 50% of the 'high-risk' children were recorded by their GPs as having egg, nut, seafood, insect venom allergy, or previous anaphylaxis.

‘Given that only half of the "high-risk" children were noted as having a previous relevant allergy or anaphylaxis diagnosis, the rationale for prescribing is, in many cases, unclear,’ said Lavanya Diwakar, lead author of the study and honorary consultant in immunology at Queen Elizabeth Hospital in Birmingham.

Sharp increase in prescribing

The study, published in the British Journal of General Practice, showed that AAI prescribing increased sharply from 2000 to 2012, with a 355% increase in the number of children prescribed devices, and a 33% increase in the number of devices prescribed per child.

Almost a quarter (24%) of the high-risk children received more than four devices in a year.  

The rate of hospital admission in England for anaphylaxis increased over the study period, although mortality rates decreased.

Based on the anaphylaxis hospitalisation rate of 7 per 100,000 in 2012, the authors estimate that approximately 400 AAI devices were prescribed per child admitted to hospital. The benefits and risks of such prescribing are not clear, they say.

Cost burden

The increase in the number of devices being prescribed places a significant financial burden on the NHS, according to the researchers. At an average cost per device of £25.80, the estimated annual expenditure on AAIs for children was approximately £7 million in 2012.

Recent guidance from the British Society for Allergy and Clinical Immunology (BSACI) suggests that only one AAI should be issued per individual, although children may be issued with two – one for home and one for school. There are no data to suggest that the provision of more than two devices can be life-saving or provide reassurance.

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

Managing anaphylaxis during an emergency

Managing anaphylaxis during an emergency

Distinguishing between an allergic reaction and anaphylaxis,...

How to manage severe allergies in primary care

How to manage severe allergies in primary care

Dr Joanne Walsh discusses the role of GPs in managing...

Childhood food allergy - paediatric medicine

Childhood food allergy - paediatric medicine

Many children outgrow allergies by school age, while...


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases